➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Boehringer Ingelheim
McKinsey
Harvard Business School
Mallinckrodt

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

PANHEMATIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: PANHEMATIN
Patents:130
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for PANHEMATIN
Recent Clinical Trials for PANHEMATIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
The University of Texas Medical Branch, GalvestonN/A
Mayo ClinicPhase 1
Rush University Medical CenterPhase 2

See all PANHEMATIN clinical trials

Patent Text Search: US Patents for PANHEMATIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for PANHEMATIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SPC/GB07/031 United Kingdom   Get Started for $10 PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
SPC/GB11/046 United Kingdom   Get Started for $10 PRODUCT NAME: LEISHMANIA INFANTUM EXCRETED SECRETED PROTEINS (ESP); REGISTERED: UK EU/2/11/121/001 20110314; UK EU/2/11/121/002 20110314; UK EU/2/11/121/003 20110314; UK EU/2/11/121/004 20110314; UK EU/2/11/121/005 20110314; UK EU/2/11/121/006 20110314; UK EU/2/11/121/007 20110314; UK EU/2/11/121/008 20110314; UK EU/2/11/121/009 20110314
27/2007 Austria   Get Started for $10 PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
0790017-8 Sweden   Get Started for $10 PRODUCT NAME: LIPIDMIKROSFAERER INNEHALLANDE PERFLUTREN; REG. NO/DATE: EU/1/06/361/001 20060920
122007000024 Germany   Get Started for $10 PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
C300495 Netherlands   Get Started for $10 PRODUCT NAME: LEISHMANIA INFANTUM EXCRETED; REGISTRATION NO/DATE: EU/2/11/121/001-009 20110314
C00698099/01 Switzerland   Get Started for $10 PRODUCT NAME: EXKRETORISCH-SEKRETORISCHE PROTEINE (ESP) VON LEISHMANIA INFANTUM; REGISTRATION NO/DATE: VI 1712 20120305
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Johnson and Johnson
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.